Analysis of the Loss of Muscle Force, Power and Motor Control to Predict the Risk of Falls in Patients With Knee OA
PowerAGING
Analisi Della Perdita di Forza e Potenza Muscolare e Del Degrado Del Controllo Motorio Per la Predizione Delle Cadute in Una Popolazione Affetta da Artrosi di Ginocchio
1 other identifier
interventional
50
1 country
1
Brief Summary
The twofold goal of this study is to understand the link between muscle power, muscle strength, and muscle control degradation with the risk of falling, and to develop a framework for the comprehensive and quantitative assessment of muscle power (and strength) in an elderly population of patients with knee osteoarthritis, who are at higher risk of falling. The main question it aims to answer is: ● Are muscle power and motor control degradation better predictors of falls than muscle strength in the aging population? Participants will undergo:
- Muscle force assessment on a dynamometer
- Muscle power assessment on a dynamometer and on isntrumented stairs
- Home-based mobility monitoring
- Full lower limb MRI acquisition
- Gait assessment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2024
CompletedFirst Posted
Study publicly available on registry
September 25, 2024
CompletedStudy Start
First participant enrolled
January 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 12, 2026
February 27, 2026
February 1, 2026
1.4 years
September 17, 2024
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximal muscle force
Maximal Isometric muscle force from dynamometry test
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Muscle power
Assessed on the dynamometer and during dynamic tasks
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Muscle activations
From surface EMG data collected on the dynamometer and during dynamic tasks (gait assessment and stair ascent/descent)
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Digital Mobility Outcomes
Qualitative and quantiative measures of real-world mobility (e.g., gait speed, stride length)
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Secondary Outcomes (2)
Musculoskeletal model predictions
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
Muscle volumes
From first follow-up visit (Month 6) to last follow-up visit (Month 24)
Study Arms (1)
Knee Osteoarthritis
EXPERIMENTALElderly patients with knee osteoarthritis, without a history of falls (in the 12 months prior to enrollment). All subjects will be followed up for 24 months, every 6 months. Muscle force and power assessments, plus a home-based mobility monitoring, will be performed at all visits. Full lower limb MRI and a gait assessment will be performed at first and last visit.
Interventions
Isokinetic dynamometry test Stair ascent/descent on instrumented stairs
Isometric dynamometry (Maximal Voluntary Isometric Contraction)
Eligibility Criteria
You may qualify if:
- Age between 65 and 80 years
- Kellgren score II e III
- No history of falls in the last 12 months
You may not qualify if:
- Any musculoskeletal, neurological, rheumatic or tumoral diseases
- Dementia
- Diabetes
- Inguinal or abdominal hernia
- Severe Hypertension (Level 3)
- Severe Cardio-pulmonary insufficiency
- Diagnosis of Osteonecrosis in the lower limb joints
- Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
- Previous interventions or traumas to the joints of the lower limb
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Istituto Ortopedico Rizzoli
Bologna, 40136, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Berti, Professor
IRCCS Istituto Ortopedico Rizzoli
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2024
First Posted
September 25, 2024
Study Start
January 30, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 12, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02